drugset
drugset / Trial / NCT04907006

A Food-drug Interaction Study of SY-004 in Healthy Subjects

NCT04907006 ↗

Phase 1 Completed 24 enrolled Suzhou Yabao Pharmaceutical R&D Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open, two cycle, double crossover, single center study was conducted to evaluate the effect of high-fat diet on the pharmacokinetics of SY-004 in healthy subjects

Timeline

Start
2021-08-31
Primary completion
2021-10-11
Completion
2021-10-11

Drugs

EvaluationDrugModalityDoseRoute
Subject LY2608204 Small molecule 80 mg Oral

Indications

type 2 diabetes mellitus